BIOPHARMA INTELLIGENCE | MARKET ACCESS

Health Economics and Value

In a constantly shifting health landscape, overcome ​ hurdles to gain access globally

Contact us

Best in class health economics and outcomes research (HEOR)

Our multi-disciplinary team offers best in class health economics and outcomes research (HEOR) and market access services to the world’s leading pharmaceutical and medical device companies.

We balance scientific rigor with commercial awareness, differentiating ourselves with innovative approaches, technical excellence, robust data and design.

Achieve all aspects of your HEOR and market access goals

  1. Innovation, technical excellence, creativity, and design.
    Real world evidence data repositories, and expert thought leadership to address evolving market challenges.
  2. Highly specialized team
    Leverage our team of health economists, medical writers, systematic review analysts and statisticians, clinical outcomes assessment analysts, creative designers, IT developers and programmers.
  3. Complete view of markets worldwide
    Our experts track the evolving landscape of health technology assessment (HTA) and global access.
  4. Meeting the demands of global payers, clinicians, policy makers and patients.
    Curated HEOR roadmaps and the assimilation, generation, and communication of the right evidence, expertly implemented and designed

Integrated health economics and market access services

Global market access

Leverage support across all market access initiatives for pharmaceutical, biotech and medical device companies.

  • Global Health Technology Assessment (HTA)
  • Strategic consulting
  • Roadmap Development

Health economics

Access solutions tailored to your exact needs, from internal corporate decision-making exercises to market access submissions, across all stages of an intervention’s life cycle, ranging from exploratory research to in‑market product support.

  • Cost effectiveness models
  • Budget impact models
  • Real world evidence

Clinical outcomes research

Develop and validate new and existing patient-reported outcomes (PROs) and other clinical outcomes assessment (COAs) used to assess important patient outcomes including symptoms, functioning, health-related quality of life (HRQoL), and treatment experience.

  • PRO/COA strategy, development, and validation
  • Qualitative and quantitative research

Evidence generation

Gain support across all aspects of the systematic literature review process, from defining the study question, to citation screening, data extraction, and qualitative data synthesis.

  • Systematic review
  • Feasibility assessment
  • Meta-analysis

Value communication

Bring products to market successfully with solution-focused, flexible approaches to evidence generation and value communication.

  • Global value dossiers / reimbursement dossiers
  • Value proposition development
  • Publications and manuscripts
  • Objection handlers

Digital tools

Leverage our in-house specialist teams of health economists, medical writers, graphic designers, and programmers to ensure your communication tool is both evidence-based and commercially relevant.

  • Budget impact models
  • Interactive global value dossier(iGVD)
  • e-detailers
  • Digital objection handlers
  • Data visualization
  • Business case generators
  • Payer decisions database
  • UI/UX design

Design

Deploy a fusion of deep scientific knowledge with agency-standard design to create simple, intelligent, and impactful communication materials.

  • Branding
  • Print collateral
  • Infographics, PowerPoints
  • Web design / Digital UI/UX Design
  • Posters and Exhibitions

Training

Leverage health economics and market access trainings including training in HEOR disciplines, consultative selling techniques, and custom curriculums that align and enable teams to immediately apply their learnings.

  • Technical training
  • Sales training
  • Bespoke training
  • Needs analysis

Related products

SOLUTION 
BIOPHARMA INTELLIGENCE 

Get started

Speak with one of our experts

Contact us